Cardinal Investors Reach $124M Settlement In Opioid Suit
Directors of Cardinal Health Inc. and the company's investors have reached a $124 million settlement resolving claims of a shareholder derivative suit that the directors failed to protect the company from...To view the full article, register now.
Already a subscriber? Click here to view full article